Health care and education reporter for @TriangleBizJrnl
Raleigh, NC
Joined November 2012
- Tweets8.3K
- Following526
- Followers1.7K
- Likes463
A global company appears on the verge of starting a massive expansion in Johnston County after buying up land in the area last year.
bizjournals.com/triangle/new…
Zac Ezzone retweeted
A Raleigh investor who has no prior experience in higher ed administration has been named interim chancellor at UNC-Chapel Hill bizjournals.com/triangle/new…
Zac Ezzone retweeted
North Carolina Community College System has a new vice president and Chief Finance Officer. bizjournals.com/triangle/new…
Zac Ezzone retweeted
Is your company growing fast .... really fast? Then nominate it for our 2023 Fast 50 Awards, celebrating the fastest-growing private companies in the #TriangleNC.
This is our biggest awards event of the year! bit.ly/43WPQVO
A multibillion-dollar company is growing its footprint in Research Triangle Park with plans for a $500M manufacturing facility.
bizjournals.com/triangle/new…
UNC-Chapel Hill has named the next dean of its business school.
bizjournals.com/triangle/new…
A gene editing company in Durham has secured a major partnership with a global pharma giant.
bizjournals.com/triangle/new…
Duke University Health System has named Craig Albanese as its next CEO.
bizjournals.com/triangle/new…
Zac Ezzone retweeted
With the U.S. set to co-host the 2026 World Cup, the nation's soccer federation is considering Cary for a new headquarters and training facility. bizjournals.com/triangle/new…
North Carolina State University is looking into building a new facility for its business school on Centennial Campus.
bizjournals.com/triangle/new…
Months after laying off employees at its Research Triangle Park facility, a Canadian vaccine maker is shutting down for good.
bizjournals.com/triangle/new…
Pfizer may look to offload a gene therapy manufacturing facility in Durham.
bizjournals.com/triangle/new…
A Durham company is facing pressure from an investor that's calling on the 'frivolous' drugmaker to move toward liquidation.
bizjournals.com/triangle/new…
Novartis is shifting all gene therapy production to Durham as it shuts down a facility outside of North Carolina.
bizjournals.com/triangle/new…
A Durham-based drug developer has combined with a public company a little more than a year after launching.
bizjournals.com/triangle/new…
UNC-Chapel Hill has named an interim dean for its business school.
bizjournals.com/triangle/new…
A Durham drugmaker can resume enrolling patients in multiple clinical trials after getting the green light from regulators.
bizjournals.com/triangle/new…
A biotechnology company with hundreds of local employees is scaling back its presence in the Triangle as part of a $1 billion cost-savings plan.
bizjournals.com/triangle/new…
A Durham biopharmaceutical company is selling its lone FDA-approved product, a smallpox treatment. But investors don't appear too happy about the deal.
bizjournals.com/triangle/new…
Two of the Triangle's largest health systems are again competing for beds in Durham County.
bizjournals.com/triangle/new…
